MedTrace Logo

SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus

NCT03819543 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-02-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether transcranial direct current stimulation affects super refractory status epilepticus.

Conditions

  • Status Epilepticus

Interventions

DEVICE

Transcranial Direct Current Stimulation

Application of transcranial direct current stimulation via scalp electrodes over presumed epileptogenic focus for 20 minutes at 2.0 mA.

Sponsors & Collaborators

  • Manitoba Medical Service Foundation

    collaborator OTHER

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Marcus Ng, MD · University of Manitoba

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-15
Primary Completion
2020-11-30
Completion
2021-08-31
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03819543 on ClinicalTrials.gov